ATL-801

• UNSPSC Description:

  ATL-801, an A2B receptor selective antagonist, ameliorates murine colitis[1].

• Target Antigen:

  Adenosine Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/atl-801.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=CC=CN=C1)N(C2=NC=C(C3=NC4=C(N(CCC)C(N(C5CC5)C4=O)=O)N3)C=C2)CC

• Molecular Weight:

  459.50

• References & Citations:

  [1]Vl Kolachala, et al. Blockade of adenosine A2B receptors ameliorates murine colitis. Br J Pharmacol. 2008 Sep;155(1):127-37.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1000005-71-9